Bellicum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The com…

Biotechnology
US, Houston [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Bellicum Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Bellicum Pharmaceuticals, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Bellicum Pharmaceuticals, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of BLCM's Analysis
CIK: 1358403 CUSIP: 079481404 ISIN: US0794814048 LEI: - UEI: -
Secondary Listings
BLCM has no secondary listings inside our databases.